Oral ingestion of a hydrolyzed gelatin meal in subjects with normal weight and in obese patients: Postprandial effect on circulating gut peptides, glucose and insulin
- 37 Downloads
Gut hormones [ghrelin, peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)] are an important group of hormones that target appetite control. They are released from endocrine L cells of the small bowel in proportion to the volume, components and calories in a meal. In the current study, 20 g of gelatin (flavored and sweetened) were given to obese patients (n=12) and lean subjects (n=10). Subsequently, plasma samples were collected at-30-minute intervals up to 180 minutes and glucose, insulin, PYY, GLP-1 and ghrelin were assayed using specific and sensitive immunofluorometric and radioimmunoassays. As expected, obese patients had normal serum glucose levels, higher serum insulin, and lower plasma concentration of ghrelin at all times compared to lean subjects. GLP-1 plasma levels were significantly elevated at 60 minutes, peaking at 120 minutes in obese patients and lean subjects. As a consequence, there was a significant rise in serum insulin levels with a significantly higher peak level at 60 min (obese) and 30 min (lean). There were no significant changes in PYY plasma concentrations and no correlation was found between body mass index and concentrations of ghrelin, PYY and GLP-1 in the group of obese patients. In conclusion, a single gelatin meal induces a rise in plasma GLP-1 followed by an increase in serum levels of insulin. These findings may be applied to maximize satiety in obese patients as a means of improving adherence to calorie-controlled diets as well as provide better control of diabetic patients.
KeywordsGhrelin GLP-1 PYY insulin glucose gelatin obesity
Unable to display preview. Download preview PDF.
- 7.Neary N.M., Small C.J., Druce M.R., Park A.J., Ellis S.M., Senijonous N.M., Dakin C.L., Filipsson K., Wang F., Kent A.S., Frost G.S., Ghatei M.A., Bloom S.R.: Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology, 146, 5120–5127, 2005.CrossRefPubMedGoogle Scholar
- 8.Verdich C., Flint A., Gutzwiller J.P., Noslund E., Beglinger C., Hellstrom P.M., Long S.J., Morjan L.M., Holst J.J., Astrup A.: A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans. J. Clin. Endocrinol. Metab., 86, 4382–4389, 2001.CrossRefPubMedGoogle Scholar
- 11.Bellissimo N., Desantadina M.V., Pencharz P.B., Berall G.B., Thomas S.G., Anderson G.H.: A comparison of short-term appetite and energy intakes in normal weight and obese boys following glucose and whey-protein drinks. Int. J. Obes., Epub. Aug 14, 1–10, 2007.Google Scholar
- 15.Lejeune M.P.G.M., Westerterp K.R., Adam T.C.M., Luscombe-Marsh N.D., Westerterp-Plantenga M.S.: Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber1-3. Am. J. Clin. Nutr., 83, 89–94, 2006.PubMedGoogle Scholar